Shares of Rocket Lab surged as much as 8.6% to $58.44 on Tuesday morning after the company loaded its next-generation Neutron rocket's upper stage and thrust module onto a barge bound for its Virginia launch site. Cantor Fitzgerald simultaneously forecast a Q2 2027 debut and reiterated a price target implying shares could more than double. The move marks the first tangible hardware milestone since an October 14 manufacturing defect pushed Neutron's inaugural flight into next year — and investors clearly needed reassurance.
Hardware at the Pad Doesn't Mean a Rocket Ready to Fly. Rocket Lab said Neutron's second stage and thrust module left the factory aboard a barge bound for Launch Complex 3 at Wallops Island.
Instead of using a traditional support tower, Neutron's only physical connection to the pad runs through its thrust module — so testing that connection lets engineers check how hardware and ground systems work together before the full rocket is assembled. The first stage, however, still needs a replacement fuel-tank dome after engineers discovered small voids in the carbon-composite layers, an issue that has been resolved but pushed the first launch to 2027.
The Stock Has a Lot of Future Baked Into Today's Price. At ~$35 billion in market value, shares trade at a forward price-to-revenue ratio of roughly 23.7×, significantly above peers, even after falling 65% from a 52-week high of $151. Rocket Lab generates about $769 million in trailing twelve-month revenue, and free cash flow is negative $371 million over the same period.
Management expects each Neutron mission to generate $50–55 million in revenue, meaningful but requiring consistent cadence to move the needle at this valuation.
A $2.36 Billion Backlog Provides a Cushion — If the Company Can Execute. Q2 revenue hit a record $234 million, up 62% year-over-year, and backlog reached $2.36 billion, up 137%.
Electron has completed 98 missions, with 19 launches so far in 2026, proving the small-rocket business is humming. But Neutron is where the growth thesis lives: Cantor's analyst believes it could become the most direct alternative to SpaceX's Falcon 9.
Wall Street Is Split on How Patient to Be. Needham held its Buy and $120 target; Citizens cut to $90; KeyBanc dropped to $100; Stifel kept Buy at $132. The consensus average target sits near $85–$102 depending on the tracker. Today's rally shows investors will reward any sign of forward motion — but with negative cash flow, a 2027 launch date, and a premium valuation, the margin for further slippage is razor-thin.